Lonza  
Careers @ Lonza | Contact us | Sitemap |
Shop
 
Home > Company > Media Center > News Archive > 2006 > Changes in Media and Investor Relations
 
Changes in Media and Investor Relations
print    
Media Releases Financial Reports Presen-tations
04/24/2006      
Changes in Media and Investor Relations


Lonza Group announces the reorganization of the Corporate Communications Group, based in Basel, Switzerland. As a result of this restructuring, some responsibilities have changed.

As of April 1, 2006, Margot Connor will head Corporate Communications and will be responsible for all English-speaking media and investor relations activities. Margot Connor will also assume the role of the media speaker of our company. Margot will take over this role from Christine Menz (Hirzel. Neef. Schmid. Konsulenten AG) who has been supporting Lonza over the past 18 months. We would like to thank Christine Menz for the excellent support and contributions.

Laura Gerber-Wieland will continue to head Investor Relations for Lonza as a whole, within the Communications Group. Simultaneously she will be promoted to Deputy Head of Corporate Communications. Laura Gerber-Wieland will be responsible for all German-speaking media and investor inquiries.

Please direct your queries to Margot Connor and Laura Gerber-Wieland, as noted be-low, and add them to your contact files.

Media
Margot Connor
Tel +41 61 316 8566
Fax +41 61 316 9566
Mobile +41 79 401 2832
margot.connor@lonza.com

Investor Relations
Laura Gerber-Wieland
Tel +41 61 316 8347
Fax +41 61 316 8220
Mobile +41 79 600 1328
laura.gerber@lonza.com

About Lonza
Lonza, a chemical and biotechnology company driven by the life sciences, generated sales of CHF 2.52 billion in 2005. Headquartered in Switzerland, Lonza operates 22 production and R&D sites around the world. Its 6300 employees are passionately committed to delivering sustainable value to their customers. Lonza is one of the lead-ing custom manufacturers of chemical intermediates, active ingredients and biophar-maceuticals for the pharmaceutical and agrochemical industries. On the basis of or-ganic chemical, oleochemical and biotechnology platforms, Lonza creates value-added solutions for the nutrition, hygiene & personal care, wood & water treatment and indus-trial specialty markets. Lonza also offers polymer intermediates, resins and com-pounds. Lonza is listed on the SWX Swiss Exchange. Further information can be found on our website www.lonza.com.


Disclaimer